Brief: GoodRx Holdings Q4 Adjusted Net Income USD 34.7 Million Vs. IBES Estimate USD 37.4 Million
27/02/2025 11:05
Feb 27 (Reuters) - GoodRx Holdings Q4 adjusted EBITDA USD 67.1 million vs. IBES estimate USD 66.4 million. Q4 adjusted EBITDA margin 33.8% Q4 net income USD 6.7 million Q4 revenue USD 198.6 million vs. IBES estimate USD 199.8 million
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million